Christopher Y. Chai, Chief Financial Officer at MAP Pharmaceuticals, Inc. (MAPP), sold 16,000 shares at $14.77 ($236K) on 2010-05-20, disclosed to the SEC on 2010-05-21.
Scheduled sale ($236k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PRNB | SELL | 2020-02-20 | $818K | — | Filing → |
| MAPP | SELL | 2011-09-22 | $492K | — | Filing → |
| MAPP | SELL | 2010-09-22 | $225K | — | Filing → |